Jeff Hansen

Jeff Hansen

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Editor

jeffhans@uab.edu | (205) 209-2355

Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.

Specific beats: 

  • Alabama Drug Discovery Alliance
  • Biochemistry and Molecular Genetics 
  • Biomatrix Engineering and Regenerative Medicine 
  • Cell biology 
  • Center for Biophysical Sciences and Engineering 
  • CCTS
  • Center for Metabolic Bone Disease 
  • Microbiology 
  • Neurobiology 
  • Comprehensive Neuroscience Center 
  • Pathology, research shared with MS2
  • Pharmacology and Toxicology 
  • Physiology and Biophysics 
  • UAB Research Foundation/IIE 
  • Research Administration

Drug developed from UAB research sharply lowers cholesterol in animal tests

Drug developed from UAB research sharply lowers cholesterol in animal tests
An Arizona drug company will patent the small peptide drug.

A novel toxin – and the first ever found – for a deadly pathogen, M. tuberculosis

A novel toxin – and the first ever found – for a deadly pathogen, M. tuberculosis
Until now, no toxin had been found in 132 years of study for the deadly pathogen Mycobacterium tuberculosis, which infects 9 million people a year and kills more than 1 million. The novel toxin induces necrotic cell death of macrophages to help the tuberculosis pathogen escape and spread to other cells.

Molecular study points to possible therapy for autoimmune disease

Molecular study points to possible therapy for autoimmune disease
The challenge is to stifle the binding of inhibitory antibodies but retain activity of a blood enzyme.

Multiple myeloma hides in bones like a wolf in sheep’s clothing

Multiple myeloma hides in bones like a wolf in sheep’s clothing
The mimicry of bone cells by multiple myeloma is driven by overexpression of Runx2, the master regulator of bone formation.

Potential drug lessens neurodegeneration in Parkinson’s disease model

Potential drug lessens neurodegeneration in Parkinson’s disease model
The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.

Autistic children improved reading and brain activity after 10-week reading intervention

Autistic children improved reading and brain activity after 10-week reading intervention
Best of 2015 2The intensive intervention was four hours a day, five days a week, for a total of 200 hours of face-to-face instruction, and neuroimaging revealed brain connectivity changes.

Cells too stiff to scavenge leads to lupus, an autoimmune disease

Cells too stiff to scavenge leads to lupus, an autoimmune disease
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.

Drug improves cognition in Alzheimer’s disease-mouse model in spite of diet

Drug improves cognition in Alzheimer’s disease-mouse model in spite of diet
This improvement in cognition persists despite a high-glycemic-index diet, a possible risk factor for Alzheimer’s.

$3.5 million UAB grant to find biomarkers that tell likelihood of suicide

$3.5 million UAB grant to find biomarkers that tell likelihood of suicide

Best of 2015 2Neuron-derived microRNAs obtained from blood samples may correlate with treatment response and could aid the search for new therapeutics.

Faye-Petersen named to leadership positions in pediatric pathology

Faye-Petersen named to leadership positions in pediatric pathology
UAB pathologist also leads a trainee in producing software to improve the quality and efficiency of perinatal autopsies.
Page 49 of 52